Skip to main content
Top
Published in: Clinical Rheumatology 1/2009

01-06-2009 | Case Report

Relapsing polychondritis—case series from South India

Authors: Rajiv Ananthakrishna, Ruchika Goel, Prasanta Padhan, John Mathew, Debashish Danda

Published in: Clinical Rheumatology | Special Issue 1/2009

Login to get access

Abstract

Relapsing polychondritis (RP) is a rare recurring inflammatory disorder with variable clinical course. It has been described mainly in Caucasian population. Reports from other ethnic groups are few. We report seven cases of relapsing polychondritis in south Indian population. In between 1995 and 2008, seven patients fulfilling the McAdam–Damiani–Levine criteria for diagnosis of relapsing polychondritis were identified. Records pertaining to these patients were studied and clinical presentation, course, and treatment offered were analyzed retrospectively. The female-to-male ratio in our series was 2.5:1. The age of onset of symptoms ranged from 28 to 54 years, with a mean of 40.2 years. An average of 20 months, ranging from 3 months to 6 years, elapsed before the patient presented to us seeking a diagnosis. Various structural involvement in our series were as follows: pinna in four (57%), nasal cartilage in five (71%), joints in three (43%), eyes in three (43%), laryngotracheal tree in three (43%), inner ear in one (14.3%), skin in one (14.3%), and heart in one (14.3%). Associated autoimmune diseases were present in four (57%) patients in the form of one of the following in each: vasculitis, autoimmune hemolytic anemia, hypothyroidism, and rheumatoid arthritis. All seven patients received prednisolone with three of them requiring additional immunosuppressants. There was no mortality amongst the four patients who had remained on follow-up at the time of this report. Although RP is an uncommon disorder, clinicians should be aware of the manifestations so as to initiate prompt treatment and prevent complications. Our series reports less frequent auricular cartilage and skin involvement and an exceptional case of basal cell carcinoma, although the other manifestations were similar to that seen in Caucasian and other Asian populations.
Literature
1.
go back to reference Foidart JM, Abe S, Martin GR, Zizic TM, Barnett EV, Lawley TJ, Katz SI (1978) Antibodies to type II collagen in relapsing polychondritis. N Engl J Med 929:1203–1207 Foidart JM, Abe S, Martin GR, Zizic TM, Barnett EV, Lawley TJ, Katz SI (1978) Antibodies to type II collagen in relapsing polychondritis. N Engl J Med 929:1203–1207
2.
go back to reference Letko E, Zafirakis P, Baltatzia S, Voudouri A, Stephen F (2002) Relapsing polychondritis: a clinical review. Semin Arthritis Rheum 31:84–95CrossRef Letko E, Zafirakis P, Baltatzia S, Voudouri A, Stephen F (2002) Relapsing polychondritis: a clinical review. Semin Arthritis Rheum 31:84–95CrossRef
3.
go back to reference Dolan DL, Lemmon GB, Teitelbaum SL (1966) Relapsing polychondritis: analytical review and studies on pathogenesis. AmJ Med 41:285–299CrossRef Dolan DL, Lemmon GB, Teitelbaum SL (1966) Relapsing polychondritis: analytical review and studies on pathogenesis. AmJ Med 41:285–299CrossRef
4.
go back to reference Kent PD, Michet CJ Jr, Luthra HS (2003) Relapsing polychondritis. Curr Opin Rheumatol 16:56–61CrossRef Kent PD, Michet CJ Jr, Luthra HS (2003) Relapsing polychondritis. Curr Opin Rheumatol 16:56–61CrossRef
5.
go back to reference Zeuner M, Straub RH, Rauh G, Albert ED, Scholmerich J, Lang B (1997) Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients. J Rheumatol 24:96–101PubMed Zeuner M, Straub RH, Rauh G, Albert ED, Scholmerich J, Lang B (1997) Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients. J Rheumatol 24:96–101PubMed
6.
go back to reference McAdam LP, O’Hanlan MA, Bluestone R, Pearson CM (1976) Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine 55:193–215PubMedCrossRef McAdam LP, O’Hanlan MA, Bluestone R, Pearson CM (1976) Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine 55:193–215PubMedCrossRef
7.
go back to reference Gergely P Jr, Poor G (2004) Relapsing polychondritis. Best Pract Res Clin Rheumatol 18(5):723–738 OctPubMedCrossRef Gergely P Jr, Poor G (2004) Relapsing polychondritis. Best Pract Res Clin Rheumatol 18(5):723–738 OctPubMedCrossRef
9.
go back to reference Yanagi T, Matsumura T, Kamekura R, Sasaki N, Hashino S (2007) Relapsing polychondritis and malignant lymphoma: is polychondritis paraneoplastic. Arch Dermatol 143(7):949–950 JulCrossRef Yanagi T, Matsumura T, Kamekura R, Sasaki N, Hashino S (2007) Relapsing polychondritis and malignant lymphoma: is polychondritis paraneoplastic. Arch Dermatol 143(7):949–950 JulCrossRef
10.
go back to reference Bhattacharjee A, Chakraborty A, Purkaystha P (2006) Prevalence of head and neck cancers in the north east—an institutional study. Indian J Otolaryngol Head Neck Surg 58(1):15–19 January–March Bhattacharjee A, Chakraborty A, Purkaystha P (2006) Prevalence of head and neck cancers in the north east—an institutional study. Indian J Otolaryngol Head Neck Surg 58(1):15–19 January–March
11.
go back to reference Trentham DE, Le CH (1998) Relapsing polychondritis. Ann Intern Med 129:114–122PubMed Trentham DE, Le CH (1998) Relapsing polychondritis. Ann Intern Med 129:114–122PubMed
12.
go back to reference Sharma A, Bambery P, Wanchu A, Sharma YP, Panda NK, Gupta A, Singh S (2007) Relapsing polychondritis in North India: a report of 10 patients. Scand J Rheumatol 36(6):462–465 Nov–DecPubMedCrossRef Sharma A, Bambery P, Wanchu A, Sharma YP, Panda NK, Gupta A, Singh S (2007) Relapsing polychondritis in North India: a report of 10 patients. Scand J Rheumatol 36(6):462–465 Nov–DecPubMedCrossRef
Metadata
Title
Relapsing polychondritis—case series from South India
Authors
Rajiv Ananthakrishna
Ruchika Goel
Prasanta Padhan
John Mathew
Debashish Danda
Publication date
01-06-2009
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue Special Issue 1/2009
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-008-1016-8

Other articles of this Special Issue 1/2009

Clinical Rheumatology 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine